Discover
RNAC
Cartesian Therapeutics, Inc.
8.59
1 x 8.40
1 x 9.81
bid
ask
-
0.17
2.00%
1 @ 04:00 PM
8.59 +0.00 (0.00%)
| Ytd | 19.07% | |
| 1y | -22.66% |
8.43
day range
8.82
5.60
52 week range
12.25
| Open | 8.82 | Prev Close | 8.76 | Low | 8.43 | High | 8.82 | Mkt Cap | 252.24M |
| Vol | 0.00 | Avg Vol | 266.61K | EPS | -3.76 | P/E | -2.28 | Forward P/E | -5.54 |
| Beta | 0.63 | Short Ratio | 15.83 | Inst. Own | 27.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 8.50 | 200-d Avg | 7.54 | 1yr Est | 38.17 |
| Income Statement | |||
| Operating Expenses | 29.16M | ||
| Research and Development Expense | 20.43M | ||
| Selling, General and Administrative Expense | 8.72M | ||
| Operating Income | -29.15M | ||
| Interest Expense | 852.00K | ||
| Net Income | 15.77M | ||
| Net Income Common Stock | 13.72M | ||
| Net Income Common Stock (USD) | 13.72M | ||
| Consolidated Income | 15.77M | ||
| Earnings per Basic Share | 0.47 | ||
| Earnings per Basic Share (USD) | 0.47 | ||
| Earnings per Diluted Share | 0.46 | ||
| Earning Before Interest & Taxes (EBIT) | 16.62M | ||
| Earning Before Interest & Taxes (USD) | 16.62M | ||
| Preferred Dividends Income Statement Impact | 2.05M | ||
| Weighted Average Shares | 29.47M | ||
| Weighted Average Shares Diluted | 29.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 147.61M | ||
| Cash and Equivalents (USD) | 147.61M | ||
| Investments | 1.74M | ||
| Investments Non-Current | 1.74M | ||
| Trade and Non-Trade Receivables | 196.00K | ||
| Current Assets | 153.62M | ||
| Property, Plant & Equipment Net | 16.43M | ||
| Total Assets | 318.63M | ||
| Debt Current | 4.20M | ||
| Total Debt | 63.85M | ||
| Current Liabilities | 20.55M | ||
| Debt Non-Current | 59.66M | ||
| Total Liabilities | 443.85M | ||
| Accumulated Retained Earnings (Deficit) | -845.79M | ||
| Accumulated Other Comprehensive Income | -4.61M | ||
| Shareholders Equity | -125.23M | ||
| Shareholders Equity (USD) | -125.23M | ||
| Assets Non-Current | 165.01M | ||
| Total Debt (USD) | 63.85M | ||
| Goodwill and Intangible Assets | 48.16M | ||
| Liabilities Non-Current | 423.30M | ||
| Trade and Non-Trade Payables | 1.05M | ||
| Tax Liabilities | 6.95M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.02M | ||
| Net Cash Flow from Financing | 50.34M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 28.97M | ||
| Capital Expenditure | -272.00K | ||
| Issuance (Purchase) of Equity Shares | 4.31M | ||
| Issuance (Repayment) of Debt Securities | 46.03M | ||
| Net Cash Flow from Investing | -272.00K | ||
| Net Cash Flow from Operations | -21.08M | ||
| Effect of Exchange Rate Changes on Cash | -25.00K | ||
| Share Based Compensation | 2.08M | ||